GlassScriptPhysician profile
Jordan White
NPI 1730804287
$3,500.27
in general payments reported to CMS, 2019-2025
16 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $1,953 · 2024: $1,548.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,453 · Education: $46.91.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,453.36 |
| Education | $46.91 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Supernus Pharmaceuticals, INC. | $1,181.34 | 2023-2024 | Qelbree, Qelbree |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $475.67 | 2023-2024 | Caplyta |
| Abbvie INC. | $384.97 | 2023-2024 | |
| Alkermes, INC. | $350.48 | 2023-2024 | Aristada, Lybalvi, Vivitrol |
| Axsome Therapeutics, INC. | $216.35 | 2023-2024 | Auvelity |
| Otsuka America Pharmaceutical, INC. | $214.68 | 2023-2024 | Rexulti, Abilify Maintena, Abilify Asimtufii |
| Lundbeck LLC | $136.48 | 2023-2024 | Rexulti |
| Idorsia Pharmaceuticals US INC | $130.78 | 2023-2024 | Quviviq |
| Corium, LLC | $78.85 | 2023-2024 | Azstarys |
| Almatica Pharma LLC | $66.34 | 2023-2024 | Loreev Xr, Sertraline Hcl |
| Tris Pharma INC | $58.21 | 2023-2024 | Dyanavel Xr |
| Ironshore Pharmaceuticals INC. | $53.12 | 2024 | |
| Janssen Pharmaceuticals, INC | $49.63 | 2023-2024 | Spravato |
| Neurocrine Biosciences, INC. | $46.30 | 2024 | Ingrezza |
| Takeda Pharmaceuticals U.S.A., INC. | $43.51 | 2023 | Trintellix |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Neos Therapeutics, LP | $13.56 | 2024 | Adzenys Xr-Odt |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jordan White listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.